FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA

K Number: K190397 · Decision Nov 15, 2019
Classifications
1
FEI Numbers
4
Registration Numbers
4
Same Product Code
1
Applicant Total
50
Review Days
269

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA
K Number
K190397
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.3590
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Immunalysis Corporation
Date Received
February 19, 2019
Decision Date
November 15, 2019
Product Code
QBK
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QBK Meprobamate Test System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (QBK), ordered by most recent decision date.

View all

Other Clearances by Immunalysis Corporation

K Number Device Name
K252520 SEFRIA™ Hydrocodone Oral Fluid
K232898 Quantisal™ Oral Fluid Collection Device
K223781 Quantisal™ II Oral Fluid Collection Device
K203647 SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay
K203564 SEFRIA Oxycodone Oral Fluid Enzyme Immunoassay
K203489 SEFRIA PCP Oral Fluid Enzyme Immunoassay
K200801 Quantisal Oral Fluid Collection Device
K183048 Quantisal II Oral Fluid Collection Device
K181135 Immunalysis SEFRIA PCP Oral Fluid Enzyme Immunoassay
K181553 Immunalysis Ethyl Alcohol Enzyme Assay
Search all 50 clearances from Immunalysis Corporation →